Sirolimus coated balloon-presentation at DCB meeting in Birmingham UK

This is the short presentation for the DCB Course held in Birmingham, UK. This course, whose Director was S. Eccleshall, gathered the most experienced DCB-players worldwide. We shared our experiences and had fun – top experiences and science for the DCB fans!

SCB early clnical experience
FINAL DCB 8pp Flyer Proof

EURO PCR 2017 – One year clinical outcome of percutaneous treatment with Sirolimus eluting balloons: Results from Nanolute prospective registry

EURO PCR 2017 – One year clinical outcome of percutaneous treatment with Sirolimus eluting balloons: Results from Nanolute prospective registry

During the EuroPCR 2017, I have presented theOne year clinical outcome of percutaneous treatment with Sirolimus eluting balloons: Results from Nanolute prospective registry.

Prospective, Multi‐center clinical registry real world, all comers patients at various indian Interventional Cardiology Sites. Clinical Follow-up at 1,6 and 12 Months.

4 IMG_3831

Conclusion

SCB might constitute a new therapeutic option, considering the overall complexity of modern-era interventional cardiology.
The results of this registry, performed in indian patients, are encouraging, but deserve more complete clinical assessment in broader patients populations.
A synergistic DCB use with new-generation DES is intriguing

Here’s the presentation of the meeting

4 NANOLUTE' presentation